Next Article in Journal
Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?
Next Article in Special Issue
Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?
Previous Article in Journal
Liposomal Irinotecan for Treatment of Colorectal Cancer in a Preclinical Model
Previous Article in Special Issue
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib
 
 
Article

Article Versions Notes

Cancers 2019, 11(3), 282; https://doi.org/10.3390/cancers11030282
Action Date Notes Link
article xml file uploaded 27 February 2019 16:13 CET Original file -
article pdf uploaded. 27 February 2019 16:13 CET Version of Record https://www.mdpi.com/2072-6694/11/3/282/pdf-vor
article xml file uploaded 1 March 2019 08:52 CET Update -
article xml uploaded. 1 March 2019 08:52 CET Update https://www.mdpi.com/2072-6694/11/3/282/xml
article pdf uploaded. 1 March 2019 08:52 CET Updated version of record https://www.mdpi.com/2072-6694/11/3/282/pdf
article html file updated 1 March 2019 08:53 CET Original file -
article html file updated 4 April 2019 04:38 CEST Update -
article html file updated 9 April 2019 17:01 CEST Update -
article html file updated 12 April 2019 05:54 CEST Update -
article html file updated 26 April 2019 10:23 CEST Update -
article html file updated 15 October 2019 18:26 CEST Update -
article html file updated 11 February 2020 18:59 CET Update https://www.mdpi.com/2072-6694/11/3/282/html
Back to TopTop